Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis

Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis

Rheumatoid arthritis (RA), afflicting over 1% of the population, is an inflammatory joint disease leading to cartilage damage and ultimately impaired joint function. Disease-modifying anti-rheumatic drugs are considered as the first-line treatment to inhibit the progression of RA, and the treatment...

Full description

Bibliographic Details
Main Authors: Shijia Liu, Yunke Guo, Lu Lu, Jiawei Lu, Mengying Ke, Tingting Xu, Yan Lu, Wenjun Chen, Jue Wang, Deshun Kong, Qiuxiang Shen, Youjuan Zhu, WenFeng Tan, Wei Ji, Wei Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
disease activity
TMT-labeled proteomics
biomarker
fibrinogen-like protein 1
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.579228/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.579228/full

Similar Items